Teva launches new “pivot to growth” strategy

Tel aviv, israel--(business wire)--teva pharmaceutical industries ltd. (nyse and tase: teva), today announced a new strategic framework with four main pillars to position the company for a new era of growth. this strategy aims to bolster the company's strong commercial portfolio with austedo®, ajovy®, uzedytm and biosimilars, amplify its innovative pipeline, sustain its generics powerhouse and focus the business. these four pillars are expected to deliver enhanced value and create a greater imp.
TEVA Ratings Summary
TEVA Quant Ranking